BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/8/2026 9:12:22 AM | Browse: 3 | Download: 18
 |
Received |
|
2025-12-05 01:31 |
 |
Peer-Review Started |
|
2025-12-05 01:31 |
 |
First Decision by Editorial Office Director |
|
2026-01-07 09:55 |
 |
Return for Revision |
|
2026-01-07 09:55 |
 |
Revised |
|
2026-02-05 16:11 |
 |
Publication Fee Transferred |
|
2026-02-09 04:10 |
 |
Second Decision by Editor |
|
2026-03-12 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-12 08:11 |
 |
Articles in Press |
|
2026-03-12 08:11 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-05-26 06:16 |
 |
Publish the Manuscript Online |
|
2026-06-08 09:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Esmolol alleviates lipopolysaccharide-induced intestinal injuries by enhancing autophagy through the AMPK/mTOR/ULK1 pathway
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yan-Bing Zhang, Zhe-Jun Yu, Jun Jin, Mao-Xia Liu, Fu-Hai Ji and Xin-Jing Yang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
82471281 |
| Key Medical Research Projects in Jiangsu Province |
ZD2022021 |
| Key R&D Program Projects in Jiangsu Province |
BE2023709 |
|
| Corresponding Author |
Xin-Jing Yang, MD, Department of Intensive Care Unit, The First Affiliated Hospital, Soochow University, No. 188 Shi-Zi Road, Suzhou 215006, Jiangsu Province, China. yangxinjingsuda@163.com |
| Key Words |
Esmolol; AMPK/mTOR/ULK1; Autophagy; Sepsis; Intestinal injury; Lipopolysaccharide |
| Core Tip |
This study investigated the protective effects of esmolol (ES), a selective β1-blocker, against lipopolysaccharide-induced septic intestinal damage. Using both animal and cell models, researchers found that ES pretreatment reduced intestinal injury markers (intestinal fatty acid-binding protein and diamine oxidase), improved tissue damage scores, and suppressed inflammation by suppressing interleukin (IL)-1 tumor necrosis factor-α, IL-17, and IL-6 while enhancing IL-10. Mechanistically, ES enhanced autophagy through activation of the AMPK/mTOR/ULK1 signaling pathway, as shown by increasing the expression of Beclin-1, LC3-II, p-AMPK, p-ULK1 and numbers of autophagosomes, and decreasing the expression of p-mTOR. These effects were consistent in both in vivo and in vitro models. The findings suggest that ES alleviates septic intestinal injury by promoting autophagy via the AMPK/mTOR/ULK1 pathway. |
| Publish Date |
2026-06-08 09:12 |
| Citation |
Zhang YB, Yu ZJ, Jin J, Liu MX, Ji FH, Yang XJ. Esmolol alleviates lipopolysaccharide-induced intestinal injuries by enhancing autophagy through the AMPK/mTOR/ULK1 pathway. World J Gastroenterol 2026; 32(23): 117320
|
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i23/117320.htm |
| DOI |
https://doi.org/10.3748/wjg.v32.i23.117320 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.